IIA
RMD icon

ICW Investment Advisors’s ResMed RMD Stock Holding History

ICW Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.72M Buy
12,105
+564
+5% +$141K 0.98% 37
2025
Q4 		$2.78M Sell
11,541
-353
-3% -$90.3K 1.01% 35
2025
Q3 		$3.26M Buy
11,894
+370
+3% +$101K 1.17% 27
2025
Q2 		$2.97M Buy
11,524
+130
+1% +$31K 1.17% 25
2025
Q1 		$2.55M Buy
11,394
+41
+0.4% +$9.57K 1.04% 31
2024
Q4 		$2.6M Buy
11,353
+77
+0.7% +$18.5K 1.08% 29
2024
Q3 		$2.75M Buy
11,276
+75
+0.7% +$16.8K 1.15% 25
2024
Q2 		$2.14M Sell
11,201
-240
-2% -$48.7K 0.97% 34
2024
Q1 		$2.27M Buy
11,441
+138
+1% +$25.3K 1.01% 32
2023
Q4 		$1.94M Buy
11,303
+249
+2% +$38.3K 0.95% 38
2023
Q3 		$1.63M Buy
11,054
+345
+3% +$62.4K 0.88% 41
2023
Q2 		$2.34M Buy
10,709
+141
+1% +$31.4K 1.26% 23
2023
Q1 		$2.31M Buy
10,568
+194
+2% +$42.1K 1.31% 19
2022
Q4 		$2.16M Sell
10,374
-101
-1% -$22.2K 1.3% 20
2022
Q3 		$2.29M Buy
10,475
+24
+0.2% +$5.46K 1.54% 13
2022
Q2 		$2.19M Sell
10,451
-28
-0.3% -$5.96K 1.4% 16
2022
Q1 		$2.54M Sell
10,479
-13
-0.1% -$3.14K 1.46% 13
2021
Q4 		$2.73M Buy
10,492
+54
+0.5% +$14K 1.53% 13
2021
Q3 		$2.75M Sell
10,438
-10
-0.1% -$2.73K 1.78% 7
2021
Q2 		$2.58M Buy
10,448
+20
+0.2% +$4.21K 1.68% 10
2021
Q1 		$2.02M Buy
10,428
+54
+0.5% +$10.8K 1.39% 14
2020
Q4 		$2.18M Sell
10,374
-292
-3% -$58.2K 1.56% 11
2020
Q3 		$1.83M Buy
10,666
+23
+0.2% +$4.25K 1.37% 17
2020
Q2 		$2.04M Sell
10,643
-155
-1% -$25.4K 1.66% 9
2020
Q1 		$1.59M Buy
10,798
+2
+0% +$319 1.51% 13
2019
Q4 		$1.67M Buy
+10,796
New +$1.56M 1.36% 17

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ICW Investment Advisors's RMD Position: Q1 2026 in Review

ICW Investment Advisors increased its ResMed (RMD) stake by 4.9% in Q1 2026, buying an estimated $141K and bringing the position to 12,105 shares worth $2.72M. The position accounts for 0.98% of the portfolio, ranked #37.

ICW Investment Advisors first reported a position in RMD in Q4 2019 and has held it in 26 quarters since. The position peaked at $3.26M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • ICW Investment Advisors held 12,105 shares of ResMed worth $2.72M as of Q1 2026.
  • ICW Investment Advisors bought 564 ResMed shares in Q1 2026, an estimated $141K.
  • ResMed made up 0.98% of ICW Investment Advisors's portfolio in Q1 2026, its #37 holding.
  • ICW Investment Advisors first reported a position in ResMed in Q4 2019 and has held it in 26 quarters since.
  • ICW Investment Advisors's ResMed position peaked at $3.26M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on ICW Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.